<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:"Segoe UI";
panose-1:2 11 5 2 4 2 4 2 2 3;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:#954F72;
text-decoration:underline;}
span.EmailStyle17
{mso-style-type:personal-compose;
font-family:"Calibri",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-family:"Calibri",sans-serif;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1028" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="#0563C1" vlink="#954F72">
<div class="WordSection1">
<p class="MsoNormal"><img width="960" height="343" style="width:10.0in;height:3.5729in" id="Picture_x0020_1" src="cid:image001.jpg@01D8B929.4C6B2E80"><o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Segoe UI",sans-serif">Medicine and laboratory testing are constantly changing. In an attempt to keep us all on the same page, the Laboratory Formulary Committee will be regularly sending out emails
with recent updates and guidances. Below are the short versions of relevant changes and attached are more in-depth guidances.<o:p></o:p></span></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><b>IgG Synthesis/Index CSF & Serum and Oligoclonal Banding CSF & Serum Order Panels:</b>
<strong><span style="font-family:"Calibri",sans-serif;font-weight:normal">To facilitate correct ordering, collection, and reporting, two new order panels went live in Epic
</span></strong><strong><span style="font-family:"Calibri",sans-serif">August 25<sup>th</sup>, 2022</span></strong><strong><span style="font-family:"Calibri",sans-serif;font-weight:normal">. The order panel for
</span></strong><strong><span style="font-family:"Calibri",sans-serif">IgG Synthesis/Index</span></strong><strong><span style="font-family:"Calibri",sans-serif;font-weight:normal"> includes orders for both the
</span></strong><strong><span style="font-family:"Calibri",sans-serif">CSF (LAB2737)</span></strong><strong><span style="font-family:"Calibri",sans-serif;font-weight:normal"> and
</span></strong><strong><span style="font-family:"Calibri",sans-serif">Serum (LAB9277)
</span></strong><strong><span style="font-family:"Calibri",sans-serif;font-weight:normal">IgG synthesis to allow for appropriate interpretation of the results. The order panel for
</span></strong><strong><span style="font-family:"Calibri",sans-serif">Oligoclonal Banding</span></strong><strong><span style="font-family:"Calibri",sans-serif;font-weight:normal"> includes orders for both the
</span></strong><strong><span style="font-family:"Calibri",sans-serif">CSF (LAB9205)</span></strong><strong><span style="font-family:"Calibri",sans-serif;font-weight:normal"> and
</span></strong><strong><span style="font-family:"Calibri",sans-serif">serum (LAB9278)</span></strong><strong><span style="font-family:"Calibri",sans-serif;font-weight:normal"> oligoclonal banding to allow for appropriate interpretation of the results. Ordering
of testing for CSF for either analyte should <u>only </u>be ordered using these order panels.<o:p></o:p></span></strong></p>
<p class="MsoNormal"><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
<v:stroke joinstyle="miter" />
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0" />
<v:f eqn="sum @0 1 0" />
<v:f eqn="sum 0 0 @1" />
<v:f eqn="prod @2 1 2" />
<v:f eqn="prod @3 21600 pixelWidth" />
<v:f eqn="prod @3 21600 pixelHeight" />
<v:f eqn="sum @0 0 1" />
<v:f eqn="prod @6 1 2" />
<v:f eqn="prod @7 21600 pixelWidth" />
<v:f eqn="sum @8 21600 0" />
<v:f eqn="prod @7 21600 pixelHeight" />
<v:f eqn="sum @10 21600 0" />
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect" />
<o:lock v:ext="edit" aspectratio="t" />
</v:shapetype><v:shape id="Picture_x0020_2" o:spid="_x0000_s1027" type="#_x0000_t75" alt="" style='position:absolute;margin-left:-85.7pt;margin-top:0;width:444.75pt;height:97pt;z-index:251661312;mso-position-horizontal:right;mso-position-horizontal-relative:text;mso-position-vertical:top;mso-position-vertical-relative:line;mso-width-relative:page;mso-height-relative:page' o:allowoverlap="f">
<v:imagedata src="cid:image002.png@01D8B929.4C6B2E80" o:href="cid:image003.png@01D8B87B.88E6E0B0" cropbottom="13107f" />
<w:wrap type="square"/>
</v:shape><![endif]--><![if !vml]><img width="593" height="129" style="width:6.177in;height:1.3437in" src="cid:image003.jpg@01D8B929.4C6B2E80" align="right" hspace="12" v:shapes="Picture_x0020_2"><![endif]><!--[if gte vml 1]><v:shape id="_x0000_s1026" type="#_x0000_t75" alt="" style='position:absolute;margin-left:0;margin-top:0;width:442.5pt;height:98.4pt;z-index:251659264;mso-position-horizontal:left;mso-position-horizontal-relative:text;mso-position-vertical:top;mso-position-vertical-relative:line;mso-width-relative:page;mso-height-relative:page' o:allowoverlap="f">
<v:imagedata src="cid:image004.png@01D8B929.4C6B2E80" o:href="cid:image002.png@01D8B87B.88E6E0B0" cropbottom="6963f" />
<w:wrap type="square"/>
</v:shape><![endif]--><![if !vml]><img width="590" height="131" style="width:6.1458in;height:1.3645in" src="cid:image005.jpg@01D8B929.4C6B2E80" align="left" hspace="12" v:shapes="_x0000_s1026"><![endif]><strong><span style="font-family:"Calibri",sans-serif;font-weight:normal"><o:p></o:p></span></strong></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><b>Theophylline and Phenobarbital testing:</b> Beginning <b>
9/1/2022</b>, testing for <b>Theophylline level (LAB35)</b> and <b>Phenobarbital level (LAB30)</b> will be performed at Downtown. Samples drawn at Community Campus will be transported to Downtown for the analysis to be performed. Please see the attached guidance
for more details.<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Segoe UI",sans-serif">For prior guidances, please visit
<a href="https://urldefense.com/v3/__https:/upstate0.sharepoint.com/sites/LaboratoryFormularyCommitteeLabchanges__;!!GobTDDpD7A!fMqwKEI3JlieL_eF-Vo4vMVj2PNzfXcL0GsxYMLCbL6cXpbRqzmyQKWIxbV1BBgJ8OlmOsFv$">
https://upstate0.sharepoint.com/sites/LaboratoryFormularyCommitteeLabchanges</a></span><o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
</body>
</html>